Provided by Tiger Fintech (Singapore) Pte. Ltd.

Amylyx Pharmaceuticals

5.52
0.0000
Post-market: 5.530.0100+0.18%19:15 EDT
Volume:890.30K
Turnover:4.87M
Market Cap:492.06M
PE:-1.83
High:5.55
Open:5.37
Low:5.33
Close:5.52
Loading ...

Amylyx files $300M mixed securities shelf

TIPRANKS
·
04 Mar

Amylyx Pharmaceuticals Inc Files for Mixed Shelf of up to $300 Mln – SEC Filing

THOMSON REUTERS
·
04 Mar

Amylyx Pharma Q4 EPS $(0.55) Misses $(0.52) Estimate

Benzinga
·
04 Mar

BRIEF-Amylyx Pharmaceuticals Q4 EPS USD -0.55

Reuters
·
04 Mar

Amylyx Pharmaceuticals Inc - Expected Cash Runway Through End of 2026

THOMSON REUTERS
·
04 Mar

Amylyx Pharmaceuticals Q4 EPS USD -0.55

THOMSON REUTERS
·
04 Mar

Press Release: Amylyx Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results

Dow Jones
·
04 Mar

Amylyx Pharmaceuticals Inc expected to post a loss of 52 cents a share - Earnings Preview

Reuters
·
28 Feb

Press Release: Amylyx Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025

Dow Jones
·
24 Feb

Amylyx Pharmaceuticals Inc expected to post a loss of 52 cents a share - Earnings Preview

Reuters
·
21 Feb

Amylyx Pharmaceuticals Inc expected to post a loss of 52 cents a share - Earnings Preview

Reuters
·
18 Feb

Amylyx Pharmaceuticals Says FDA Lifts Clinical Hold on Phase 1 ALS Study

MT Newswires Live
·
21 Jan

Amylyx Pharmaceuticals Inc - to Move Forward With Trial Sites Across North America

THOMSON REUTERS
·
21 Jan

Amylyx Pharmaceuticals Announces FDA Has Lifted the Clinical Hold on Amx0114 Phase 1 Clinical Trial for the Treatment of Amyotrophic Lateral Sclerosis

THOMSON REUTERS
·
21 Jan

Amylyx Pharmaceuticals Inc - to Initiate Phase 1 Lumina Trial in Canada in Early 2025

THOMSON REUTERS
·
21 Jan

Amylyx Pharmaceuticals Prices $60 Million Common Stock Offering

MT Newswires Live
·
10 Jan

BRIEF-Amylyx Pharmaceuticals Prices Public Offering Of Common Stock

Reuters
·
10 Jan

Amylyx Pharmaceuticals Inc - Gross Proceeds Expected to Be Approximately $60 Million

THOMSON REUTERS
·
10 Jan

Amylyx Pharmaceuticals Announces Pricing of Public Offering of Common Stock

THOMSON REUTERS
·
10 Jan

Amylyx Pharmaceuticals Inc - Prices Public Offering of 17,142,857 Shares at $3.50 per Share

THOMSON REUTERS
·
10 Jan